17:08 EST Lucid Diagnostics (LUCD) files $175M mixed securities shelf
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LUCD:
- Lucid Diagnostics: Buy Rating Backed by Strong Growth, Financial Stability, and Strategic Expansion
- Lucid Diagnostics: Positive Indicators and Medicare Reimbursement Potential Support Buy Rating
- Positive Outlook for Lucid Diagnostics: Buy Rating Affirmed Amid Growth in EsoGuard Test Volumes and Strong Financial Management
- Lucid Diagnostics Reports Q3 2025 Financial Results
- Lucid Diagnostics’ Earnings Call: Strategic Wins Amid Challenges